Search

Displaying results 4091 - 4100 of 10000 in total
  1. Drug

    Cipaglucosidase alfa

    go.drugbank.com/drugs/DB16708
    ApprovedInvestigational

    Cipaglucosidase alfa (ATB200) is a novel recombinant human acid alpha-glucosidase (GAA) investigated for the treatment of patients with Pompe disease, a rare inherited metabolic disorder characterized by … Cipaglucosidase alfa is conjugated with mannose-6-phosphate (M6P) N-glycans that bind to the cation-independent mannose-6-phosphate receptor (CI-MPR) in skeletal muscle, one of the main affected tissues

  2. Drug

    Barbexaclone

    go.drugbank.com/drugs/DB09001
    Experimental

    Pharmacokinetic studies have demonstrated that the pharmacokinetics of phenobarbital given as barbexaclone are not affected by propylhexedrine. … With this difference in potency in mind, other pharmacokinetic considerations such as dose titration, daily dosing, and optimal plasma concentration can be considered the same as for the equivalent amount

  3. Drug

    Nelotanserin

    go.drugbank.com/drugs/DB12555
    Investigational

    It increases non-REM sleep, the most restorative phase of the sleep cycle, without sacrificing REM or dream sleep.

  4. Indication

    Ulcers, Leg

    go.drugbank.com/conditions/DBCOND0125075
    Drugs: Chlorhexidine · Lidocaine
    Synonyms: Leg ulcer NOS, Skin ulcer NOS
  5. Indication

    Chronic Ulcer of Skin

    go.drugbank.com/conditions/DBCOND0159402
    Drugs: Hyaluronic acid
    Synonyms: Non-pressure chronic ulcer of skin, not elsewhere classified, Skin ulcer NOS
  6. Indication

    Noncystic Fibrosis Bronchiectasis (NCFB)

    go.drugbank.com/conditions/DBCOND0134357
    Drugs: Brensocatib
    Synonyms: Bronchiectasis NOS, Bronchiectasis, NOS
  7. Drug

    INNO-305

    go.drugbank.com/drugs/DB06025
    Investigational

    INNO-305 is an investigational vaccine developed by Innovive Pharmaceuticals for the treatment of patients with acute myeloid leukemia in complete remission.

  8. Drug

    Dengue virus serotype 2

    go.drugbank.com/drugs/DB22665
    Approved

    [A274008] It is one of four serotypes covered by Qdenga, a live, attenuated, tetravalent vaccine used for the prevention of dengue disease.

  9. Drug

    Dengue virus serotype 3

    go.drugbank.com/drugs/DB22666
    Approved

    [A274008] It is one of four serotypes covered by Qdenga, a live, attenuated, tetravalent vaccine used for the prevention of dengue disease.

  10. Drug

    Etilamfetamine

    go.drugbank.com/drugs/DB13285
    Experimental

    However, being on the controlled drug and substance act does not necessitate that the drug is approved for sale on the market. … Etilamfetamine is also known as N-ethylamphetamine and is in the Canadian Legislation - The Controlled Drugs and Substances Act, and is a Schedule 1 controlled drug.